This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Janssen Pharmaceutica Nv. Active years: 2013-2014.
Location History:
- Renton, WA (US) (2013)
- San Diego, CA (US) (2014)
Company Filing History:
Years Active: 2013-2014
Title: Amy K Timmons: Innovator in Pharmaceutical Chemistry
Introduction
Amy K Timmons is a prominent inventor based in Renton, WA (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target fatty acid amide hydrolase (FAAH). With a total of 3 patents, her work has the potential to impact various medical conditions.
Latest Patents
Among her latest patents, Timmons has developed heteroaryl-substituted urea modulators of fatty acid amide hydrolase. These compounds are designed to act as FAAH inhibitors, which can be utilized in pharmaceutical compositions. The applications of these compounds extend to the treatment of several disease states, disorders, and conditions mediated by FAAH activity, including anxiety, pain, inflammation, sleep disorders, eating disorders, insulin resistance, diabetes, osteoporosis, and movement disorders such as multiple sclerosis.
Career Highlights
Throughout her career, Amy K Timmons has worked with notable companies in the pharmaceutical industry, including Janssen Pharmaceutica NV and Janssen Pharmaceutica BV. Her expertise in the field has allowed her to contribute to innovative solutions in drug development.
Collaborations
Timmons has collaborated with esteemed colleagues such as J Guy Breitenbucher and John M Keith, further enhancing her research and development efforts in the pharmaceutical sector.
Conclusion
Amy K Timmons stands out as a dedicated inventor whose work in pharmaceutical chemistry is paving the way for new treatments for various medical conditions. Her innovative contributions continue to shape the future of drug development.